House Bill 2589
115th Congress(2017-2018)
Huntington's Disease Parity Act of 2017
Introduced
Introduced in House on May 22, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2589
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Huntington's Disease Parity Act of 2017
This bill amends title II (Old-Age, Survivors, and Disability Insurance) (OASDI) of the Social Security Act to waive, for individuals diagnosed with Huntington's Disease, the 24-month waiting period for Medicare coverage. Current law generally applies this waiting period to individuals deemed eligible for OASDI benefits.
May 22, 2017
06/02/2017
Referred to the Subcommittee on Health.
05/22/2017
Referred to the House Committee on Ways and Means.
05/22/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:36:41 PM